Blue-Button Screening for Cancer Trials Enrollment
What You Need to Know Before You Apply
What is the purpose of this trial?
Enrollment in clinical trials predicts better survival in the most common cancer types including breast cancer, and testing and proving the efficacy of new treatments relies on successfully conducting clinical trials. However, approximately one fifth of cancer clinical trials fail due to insufficient patient enrollment, and only about 6% of adult cancer patients are enrolled onto clinical trials. Barriers remain for patient participation in clinical trials, especially for cancer patients. One specific barrier is trial identification and awareness of trial availability for both patients and providers.This trial tests the hypothesis that by integrating clinical trial eligibility screening into part of routine care in a way that requires little effort and by making that screening site agnostic, the Blue-Button matching functionality will increase overall cancer clinical trial enrollment, and may also result in more diverse clinical trial participants that better reflect the U.S. cancer population. Moreover, regardless of changes in enrollment, the Blue-button screening may allow screening to be done more quickly with fewer human resources when compared to current methods. Identification of potential trial opportunities, however, is only the first barrier to trial enrollment, so this study includes additional examination of barriers subsequent to the identification of relevant trials by cataloging patient-level barriers that prevent enrollment of patients in identified trials.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
How does the Blue-Button Screening treatment differ from other cancer treatments?
The Blue-Button Screening treatment is unique because it focuses on using electronic health records to automatically match cancer patients with clinical trials, potentially increasing trial participation and improving representation of diverse populations. This approach differs from traditional treatments as it emphasizes trial enrollment rather than direct medical intervention.12345
What data supports the effectiveness of the treatment Blue-button screening for cancer trials enrollment?
The research highlights the importance of effective screening processes in improving cancer trial enrollment, particularly for underrepresented populations. While not directly about Blue-button screening, the studies suggest that automated and comprehensive screening methods can enhance trial participation and potentially improve cancer outcomes.12678
Who Is on the Research Team?
Mark Fleury, PhD
Principal Investigator
ACS CAN
Are You a Good Fit for This Trial?
This trial is for adult cancer patients who are visiting the clinic and could be screened for clinical trial participation. It aims to integrate a new method of identifying suitable trials as part of routine care, potentially increasing enrollment and diversity in cancer clinical trials.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Blue-button screening
Subjects have deidentified data elements transferred from their EHR to the Blue-button tool for identification of clinical trials for which they may be eligible.
Follow-up
Participants are monitored for trial participation and reasons for non-enrollment.
What Are the Treatments Tested in This Trial?
Interventions
- Blue-button screening
Find a Clinic Near You
Who Is Running the Clinical Trial?
American Cancer Society Cancer Action Network
Lead Sponsor